{"id":3055,"date":"2026-09-04T12:05:00","date_gmt":"2026-09-04T06:35:00","guid":{"rendered":"https:\/\/www.bullscreen.in\/news\/?p=3055"},"modified":"2026-09-04T11:38:31","modified_gmt":"2026-09-04T06:08:31","slug":"zydus-lifesciences-branded-drugs-revenue-ebitda-margin-30-percent","status":"publish","type":"post","link":"https:\/\/www.bullscreen.in\/news\/zydus-lifesciences-branded-drugs-revenue-ebitda-margin-30-percent\/","title":{"rendered":"Zydus Lifesciences: 55% \u0938\u0947 66%+ \u0939\u094b\u0917\u093e Branded Drugs \u0915\u093e \u0939\u093f\u0938\u094d\u0938\u093e, \u0915\u094d\u092f\u093e EBITDA Margin \u092a\u0939\u0941\u0902\u091a\u0947\u0917\u093e 30%?"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.bullscreen.in\/company\/ZYDUSLIFE\" target=\"_blank\" rel=\"noopener\" title=\"\">Zydus Lifesciences<\/a> \u0928\u0947 FY27 \u0915\u0940 \u0936\u0941\u0930\u0941\u0906\u0924 \u092e\u091c\u092c\u0942\u0924 \u092a\u094d\u0930\u0926\u0930\u094d\u0936\u0928 \u0915\u0947 \u0938\u093e\u0925 \u0915\u0940 \u0939\u0948\u0964 \u0939\u093e\u0932\u093e\u0902\u0915\u093f \u0928\u093f\u0935\u0947\u0936\u0915\u094b\u0902 \u0915\u0947 \u0932\u093f\u090f \u091c\u094d\u092f\u093e\u0926\u093e \u0905\u0939\u092e \u092c\u093e\u0924 \u0915\u0902\u092a\u0928\u0940 \u0915\u0947 <strong>Revenue Mix<\/strong> \u092e\u0947\u0902 \u0939\u094b \u0930\u0939\u093e \u092c\u0926\u0932\u093e\u0935 \u0939\u0948\u0964 \u0915\u0902\u092a\u0928\u0940 \u092d\u093e\u0930\u0924 \u0914\u0930 \u0905\u092e\u0947\u0930\u093f\u0915\u093e \u092e\u0947\u0902 \u092c\u094d\u0930\u093e\u0902\u0921\u0947\u0921, \u0915\u094d\u0930\u0949\u0928\u093f\u0915 \u0914\u0930 \u0938\u094d\u092a\u0947\u0936\u093f\u092f\u0932\u093f\u091f\u0940 \u0926\u0935\u093e\u0913\u0902 \u0915\u093e \u0939\u093f\u0938\u094d\u0938\u093e \u092c\u0922\u093c\u093e \u0930\u0939\u0940 \u0939\u0948, \u091c\u093f\u0938\u0938\u0947 \u0932\u0902\u092c\u0947 \u0938\u092e\u092f \u092e\u0947\u0902 \u092e\u0941\u0928\u093e\u092b\u0947 \u0915\u0940 \u0915\u094d\u0937\u092e\u0924\u093e \u092c\u0947\u0939\u0924\u0930 \u0939\u094b \u0938\u0915\u0924\u0940 \u0939\u0948\u0964<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u0915\u0902\u092a\u0928\u0940 \u0915\u093e Q1 FY27 \u0915\u0902\u0938\u094b\u0932\u093f\u0921\u0947\u091f\u0947\u0921 \u0930\u0947\u0935\u0947\u0928\u094d\u092f\u0942 22% \u092c\u0922\u093c\u0915\u0930 \u20b98,020 \u0915\u0930\u094b\u0921\u093c \u0930\u0939\u093e\u0964 EBITDA \u20b91,930 \u0915\u0930\u094b\u0921\u093c \u0914\u0930 EBITDA Margin 24.1% \u0930\u0939\u093e, \u091c\u092c\u0915\u093f \u0928\u0947\u091f \u092a\u094d\u0930\u0949\u092b\u093f\u091f \u20b9940 \u0915\u0930\u094b\u0921\u093c \u0930\u0939\u093e\u0964 \u092e\u094c\u091c\u0942\u0926\u093e \u0938\u092e\u092f \u092e\u0947\u0902 <strong>Branded Products<\/strong> \u0915\u0902\u092a\u0928\u0940 \u0915\u0947 \u0915\u0941\u0932 \u0930\u0947\u0935\u0947\u0928\u094d\u092f\u0942 \u092e\u0947\u0902 55% \u0938\u0947 \u091c\u094d\u092f\u093e\u0926\u093e \u092f\u094b\u0917\u0926\u093e\u0928 \u0926\u0947 \u0930\u0939\u0947 \u0939\u0948\u0902\u0964 \u092e\u0948\u0928\u0947\u091c\u092e\u0947\u0902\u091f \u0915\u093e \u0932\u0915\u094d\u0937\u094d\u092f \u092e\u0927\u094d\u092f\u092e \u0905\u0935\u0927\u093f \u092e\u0947\u0902 \u0907\u0938\u0947 66% \u0938\u0947 \u090a\u092a\u0930 \u0932\u0947 \u091c\u093e\u0928\u0947 \u0915\u093e \u0939\u0948\u0964<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u092d\u093e\u0930\u0924 \u092e\u0947\u0902 \u092c\u094d\u0930\u093e\u0902\u0921\u0947\u0921 \u092b\u0949\u0930\u094d\u092e\u094d\u092f\u0941\u0932\u0947\u0936\u0928 \u0915\u093e\u0930\u094b\u092c\u093e\u0930 20% YoY \u092c\u0922\u093c\u093e\u0964 \u0915\u094d\u0930\u0949\u0928\u093f\u0915 \u0914\u0930 \u0938\u092c-\u0915\u094d\u0930\u0949\u0928\u093f\u0915 \u092a\u094b\u0930\u094d\u091f\u092b\u094b\u0932\u093f\u092f\u094b \u0905\u092c 54.2% \u092f\u094b\u0917\u0926\u093e\u0928 \u0926\u0947\u0924\u093e \u0939\u0948\u0964 \u0935\u0939\u0940\u0902, \u0905\u092e\u0947\u0930\u093f\u0915\u093e \u092e\u0947\u0902 \u0928\u0949\u0930\u094d\u0925 \u0905\u092e\u0947\u0930\u093f\u0915\u093e \u0930\u0947\u0935\u0947\u0928\u094d\u092f\u0942 \u20b93,100 \u0915\u0930\u094b\u0921\u093c \u0930\u0939\u093e, \u091c\u094b \u0924\u093f\u092e\u093e\u0939\u0940 \u0906\u0927\u093e\u0930 \u092a\u0930 5% \u092c\u0922\u093c\u093e\u0964 \u0905\u092e\u0947\u0930\u093f\u0915\u0940 \u0915\u093e\u0930\u094b\u092c\u093e\u0930 \u092e\u0947\u0902 \u092c\u094d\u0930\u093e\u0902\u0921\u0947\u0921 \u0909\u0924\u094d\u092a\u093e\u0926\u094b\u0902 \u0915\u093e \u092f\u094b\u0917\u0926\u093e\u0928 \u0915\u0930\u0940\u092c 10% \u0939\u0948, \u091c\u093f\u0938\u0947 FY27 \u0915\u0947 \u0905\u0902\u0924 \u0924\u0915 15% \u0938\u0947 \u090a\u092a\u0930 \u0932\u0947 \u091c\u093e\u0928\u0947 \u0915\u093e \u0932\u0915\u094d\u0937\u094d\u092f \u0939\u0948\u0964<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u0915\u0902\u092a\u0928\u0940 FY27 \u092e\u0947\u0902 \u0915\u0930\u0940\u092c 24% EBITDA Margin \u0915\u093e \u0905\u0928\u0941\u092e\u093e\u0928 \u0930\u0916\u0924\u0940 \u0939\u0948, \u0932\u0947\u0915\u093f\u0928 \u0905\u0917\u0932\u0947 \u0915\u0930\u0940\u092c \u092a\u093e\u0902\u091a \u0935\u0930\u094d\u0937\u094b\u0902 \u092e\u0947\u0902 \u0907\u0938\u0947 <strong>28-30%<\/strong> \u0924\u0915 \u092a\u0939\u0941\u0902\u091a\u093e\u0928\u0947 \u0915\u0940 \u0909\u092e\u094d\u092e\u0940\u0926 \u0939\u0948\u0964 \u0907\u0938\u0915\u0947 \u092a\u0940\u091b\u0947 \u092c\u094d\u0930\u093e\u0902\u0921\u0947\u0921, \u0938\u094d\u092a\u0947\u0936\u093f\u092f\u0932\u093f\u091f\u0940 \u0914\u0930 \u0930\u0947\u092f\u0930-\u0921\u093f\u091c\u0940\u091c \u0915\u093e\u0930\u094b\u092c\u093e\u0930 \u0915\u0940 \u092c\u0922\u093c\u0924\u0940 \u0939\u093f\u0938\u094d\u0938\u0947\u0926\u093e\u0930\u0940 \u092a\u094d\u0930\u092e\u0941\u0916 \u0915\u093e\u0930\u0923 \u0939\u0948\u0964<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u0939\u093e\u0932\u093e\u0902\u0915\u093f \u20b91,500-1,600 \u0915\u0930\u094b\u0921\u093c \u0915\u093e \u092a\u094d\u0930\u0938\u094d\u0924\u093e\u0935\u093f\u0924 <strong>Capex<\/strong>, R&amp;D \u0928\u093f\u0935\u0947\u0936 \u0914\u0930 Saroglitazar \u0915\u0947 \u0905\u092e\u0947\u0930\u093f\u0915\u0940 \u0932\u0949\u0928\u094d\u091a \u092a\u0930 \u0916\u0930\u094d\u091a \u0928\u093f\u0915\u091f \u0905\u0935\u0927\u093f \u092e\u0947\u0902 \u092e\u093e\u0930\u094d\u091c\u093f\u0928 \u092a\u0930 \u0926\u092c\u093e\u0935 \u0921\u093e\u0932 \u0938\u0915\u0924\u0947 \u0939\u0948\u0902\u0964 \u0907\u0938\u0932\u093f\u090f 30% \u092e\u093e\u0930\u094d\u091c\u093f\u0928 \u0915\u093e \u0932\u0915\u094d\u0937\u094d\u092f \u0924\u0924\u094d\u0915\u093e\u0932 \u0928\u0939\u0940\u0902, \u092c\u0932\u094d\u0915\u093f \u0926\u0940\u0930\u094d\u0918\u0915\u093e\u0932\u0940\u0928 \u0905\u0935\u0938\u0930 \u0939\u0948\u0964<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Zydus Lifesciences \u0928\u0947 FY27 \u0915\u0940 \u0936\u0941\u0930\u0941\u0906\u0924 \u092e\u091c\u092c\u0942\u0924 \u092a\u094d\u0930\u0926\u0930\u094d\u0936\u0928 \u0915\u0947 \u0938\u093e\u0925 \u0915\u0940 \u0939\u0948\u0964 \u0939\u093e\u0932\u093e\u0902\u0915\u093f \u0928\u093f\u0935\u0947\u0936\u0915\u094b\u0902 \u0915\u0947&#8230;<\/p>\n","protected":false},"author":2,"featured_media":3056,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[158],"class_list":["post-3055","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-healthcare","tag-zyduslife"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.1.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"Zydus Lifesciences \u092e\u0947\u0902 branded drugs \u0915\u093e \u0939\u093f\u0938\u094d\u0938\u093e 66%+ \u0939\u094b\u0928\u0947 \u0915\u093e \u0932\u0915\u094d\u0937\u094d\u092f \u0939\u0948\u0964 \u091c\u093e\u0928\u0947\u0902 \u0915\u094d\u092f\u093e \u092c\u0922\u093c\u0924\u093e branded mix EBITDA margin \u0915\u094b 30% \u0924\u0915 \u092a\u0939\u0941\u0902\u091a\u093e \u0938\u0915\u0924\u093e \u0939\u0948\u0964\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"BullScreen Editorial Team\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.bullscreen.in\/news\/zydus-lifesciences-branded-drugs-revenue-ebitda-margin-30-percent\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.1.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"NSE &amp; BSE Stock Market News - BULLSCREEN - Smart analysis for smart decisions.\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Zydus Lifesciences: 55% \u0938\u0947 66%+ \u0939\u094b\u0917\u093e Branded Drugs \u0915\u093e \u0939\u093f\u0938\u094d\u0938\u093e, \u0915\u094d\u092f\u093e EBITDA Margin \u092a\u0939\u0941\u0902\u091a\u0947\u0917\u093e 30%? - BULLSCREEN\" \/>\n\t\t<meta property=\"og:description\" content=\"Zydus Lifesciences \u092e\u0947\u0902 branded drugs \u0915\u093e \u0939\u093f\u0938\u094d\u0938\u093e 66%+ \u0939\u094b\u0928\u0947 \u0915\u093e \u0932\u0915\u094d\u0937\u094d\u092f \u0939\u0948\u0964 \u091c\u093e\u0928\u0947\u0902 \u0915\u094d\u092f\u093e \u092c\u0922\u093c\u0924\u093e branded mix EBITDA margin \u0915\u094b 30% \u0924\u0915 \u092a\u0939\u0941\u0902\u091a\u093e \u0938\u0915\u0924\u093e \u0939\u0948\u0964\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.bullscreen.in\/news\/zydus-lifesciences-branded-drugs-revenue-ebitda-margin-30-percent\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/www.bullscreen.in\/news\/wp-content\/uploads\/2026\/09\/zydus-lifesciences-branded-drugs-revenue-ebitda-margin-30-percent.jpg\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/www.bullscreen.in\/news\/wp-content\/uploads\/2026\/09\/zydus-lifesciences-branded-drugs-revenue-ebitda-margin-30-percent.jpg\" \/>\n\t\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-09-04T06:35:00+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-09-04T06:08:31+00:00\" \/>\n\t\t<meta property=\"article:author\" content=\"https:\/\/www.facebook.com\/Bullscreen\/\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Zydus Lifesciences: 55% \u0938\u0947 66%+ \u0939\u094b\u0917\u093e Branded Drugs \u0915\u093e \u0939\u093f\u0938\u094d\u0938\u093e, \u0915\u094d\u092f\u093e EBITDA Margin \u092a\u0939\u0941\u0902\u091a\u0947\u0917\u093e 30%? - BULLSCREEN\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Zydus Lifesciences \u092e\u0947\u0902 branded drugs \u0915\u093e \u0939\u093f\u0938\u094d\u0938\u093e 66%+ \u0939\u094b\u0928\u0947 \u0915\u093e \u0932\u0915\u094d\u0937\u094d\u092f \u0939\u0948\u0964 \u091c\u093e\u0928\u0947\u0902 \u0915\u094d\u092f\u093e \u092c\u0922\u093c\u0924\u093e branded mix EBITDA margin \u0915\u094b 30% \u0924\u0915 \u092a\u0939\u0941\u0902\u091a\u093e \u0938\u0915\u0924\u093e \u0939\u0948\u0964\" \/>\n\t\t<meta name=\"twitter:creator\" content=\"@Bullscreen_\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/www.bullscreen.in\/news\/wp-content\/uploads\/2026\/09\/zydus-lifesciences-branded-drugs-revenue-ebitda-margin-30-percent.jpg\" \/>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Zydus Lifesciences: 55% \u0938\u0947 66%+ \u0939\u094b\u0917\u093e Branded Drugs \u0915\u093e \u0939\u093f\u0938\u094d\u0938\u093e, \u0915\u094d\u092f\u093e EBITDA Margin \u092a\u0939\u0941\u0902\u091a\u0947\u0917\u093e 30%? - BULLSCREEN","description":"Zydus Lifesciences \u092e\u0947\u0902 branded drugs \u0915\u093e \u0939\u093f\u0938\u094d\u0938\u093e 66%+ \u0939\u094b\u0928\u0947 \u0915\u093e \u0932\u0915\u094d\u0937\u094d\u092f \u0939\u0948\u0964 \u091c\u093e\u0928\u0947\u0902 \u0915\u094d\u092f\u093e \u092c\u0922\u093c\u0924\u093e branded mix EBITDA margin \u0915\u094b 30% \u0924\u0915 \u092a\u0939\u0941\u0902\u091a\u093e \u0938\u0915\u0924\u093e \u0939\u0948\u0964","canonical_url":"https:\/\/www.bullscreen.in\/news\/zydus-lifesciences-branded-drugs-revenue-ebitda-margin-30-percent\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":null,"og:locale":"en_US","og:site_name":"NSE &amp; BSE Stock Market News - BULLSCREEN - Smart analysis for smart decisions.","og:type":"article","og:title":"Zydus Lifesciences: 55% \u0938\u0947 66%+ \u0939\u094b\u0917\u093e Branded Drugs \u0915\u093e \u0939\u093f\u0938\u094d\u0938\u093e, \u0915\u094d\u092f\u093e EBITDA Margin \u092a\u0939\u0941\u0902\u091a\u0947\u0917\u093e 30%? - BULLSCREEN","og:description":"Zydus Lifesciences \u092e\u0947\u0902 branded drugs \u0915\u093e \u0939\u093f\u0938\u094d\u0938\u093e 66%+ \u0939\u094b\u0928\u0947 \u0915\u093e \u0932\u0915\u094d\u0937\u094d\u092f \u0939\u0948\u0964 \u091c\u093e\u0928\u0947\u0902 \u0915\u094d\u092f\u093e \u092c\u0922\u093c\u0924\u093e branded mix EBITDA margin \u0915\u094b 30% \u0924\u0915 \u092a\u0939\u0941\u0902\u091a\u093e \u0938\u0915\u0924\u093e \u0939\u0948\u0964","og:url":"https:\/\/www.bullscreen.in\/news\/zydus-lifesciences-branded-drugs-revenue-ebitda-margin-30-percent\/","og:image":"https:\/\/www.bullscreen.in\/news\/wp-content\/uploads\/2026\/09\/zydus-lifesciences-branded-drugs-revenue-ebitda-margin-30-percent.jpg","og:image:secure_url":"https:\/\/www.bullscreen.in\/news\/wp-content\/uploads\/2026\/09\/zydus-lifesciences-branded-drugs-revenue-ebitda-margin-30-percent.jpg","og:image:width":"1200","og:image:height":"675","article:published_time":"2026-09-04T06:35:00+00:00","article:modified_time":"2026-09-04T06:08:31+00:00","article:author":"https:\/\/www.facebook.com\/Bullscreen\/","twitter:card":"summary_large_image","twitter:title":"Zydus Lifesciences: 55% \u0938\u0947 66%+ \u0939\u094b\u0917\u093e Branded Drugs \u0915\u093e \u0939\u093f\u0938\u094d\u0938\u093e, \u0915\u094d\u092f\u093e EBITDA Margin \u092a\u0939\u0941\u0902\u091a\u0947\u0917\u093e 30%? - BULLSCREEN","twitter:description":"Zydus Lifesciences \u092e\u0947\u0902 branded drugs \u0915\u093e \u0939\u093f\u0938\u094d\u0938\u093e 66%+ \u0939\u094b\u0928\u0947 \u0915\u093e \u0932\u0915\u094d\u0937\u094d\u092f \u0939\u0948\u0964 \u091c\u093e\u0928\u0947\u0902 \u0915\u094d\u092f\u093e \u092c\u0922\u093c\u0924\u093e branded mix EBITDA margin \u0915\u094b 30% \u0924\u0915 \u092a\u0939\u0941\u0902\u091a\u093e \u0938\u0915\u0924\u093e \u0939\u0948\u0964","twitter:creator":"@Bullscreen_","twitter:image":"https:\/\/www.bullscreen.in\/news\/wp-content\/uploads\/2026\/09\/zydus-lifesciences-branded-drugs-revenue-ebitda-margin-30-percent.jpg"},"aioseo_meta_data":{"post_id":"3055","title":"#post_title #separator_sa BULLSCREEN","description":"Zydus Lifesciences \u092e\u0947\u0902 branded drugs \u0915\u093e \u0939\u093f\u0938\u094d\u0938\u093e 66%+ \u0939\u094b\u0928\u0947 \u0915\u093e \u0932\u0915\u094d\u0937\u094d\u092f \u0939\u0948\u0964 \u091c\u093e\u0928\u0947\u0902 \u0915\u094d\u092f\u093e \u092c\u0922\u093c\u0924\u093e branded mix EBITDA margin \u0915\u094b 30% \u0924\u0915 \u092a\u0939\u0941\u0902\u091a\u093e \u0938\u0915\u0924\u093e \u0939\u0948\u0964","keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"featured","og_image_url":"https:\/\/www.bullscreen.in\/news\/wp-content\/uploads\/2026\/09\/zydus-lifesciences-branded-drugs-revenue-ebitda-margin-30-percent.jpg","og_image_width":"1200","og_image_height":"675","og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"featured","twitter_image_url":"https:\/\/www.bullscreen.in\/news\/wp-content\/uploads\/2026\/09\/zydus-lifesciences-branded-drugs-revenue-ebitda-margin-30-percent.jpg","twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"BlogPosting","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":{"faqs":[],"keyPoints":[],"schemas":[],"titles":[],"descriptions":[],"socialPosts":{"email":{"subject":"","preview":"","content":""},"linkedin":[],"twitter":[],"facebook":[],"instagram":[]}},"created":"2026-09-04 06:08:32","updated":"2026-09-04 07:59:06","seo_analyzer_scan_date":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.bullscreen.in\/news\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.bullscreen.in\/news\/sector\/healthcare\/\" title=\"Pharma &amp; Healthcare\">Pharma &amp; Healthcare<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tZydus Lifesciences: 55% \u0938\u0947 66%+ \u0939\u094b\u0917\u093e Branded Drugs \u0915\u093e \u0939\u093f\u0938\u094d\u0938\u093e, \u0915\u094d\u092f\u093e EBITDA Margin \u092a\u0939\u0941\u0902\u091a\u0947\u0917\u093e 30%?\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.bullscreen.in\/news"},{"label":"Pharma &amp; Healthcare","link":"https:\/\/www.bullscreen.in\/news\/sector\/healthcare\/"},{"label":"Zydus Lifesciences: 55% \u0938\u0947 66%+ \u0939\u094b\u0917\u093e Branded Drugs \u0915\u093e \u0939\u093f\u0938\u094d\u0938\u093e, \u0915\u094d\u092f\u093e EBITDA Margin \u092a\u0939\u0941\u0902\u091a\u0947\u0917\u093e 30%?","link":"https:\/\/www.bullscreen.in\/news\/zydus-lifesciences-branded-drugs-revenue-ebitda-margin-30-percent\/"}],"_links":{"self":[{"href":"https:\/\/www.bullscreen.in\/news\/wp-json\/wp\/v2\/posts\/3055","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.bullscreen.in\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bullscreen.in\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bullscreen.in\/news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bullscreen.in\/news\/wp-json\/wp\/v2\/comments?post=3055"}],"version-history":[{"count":2,"href":"https:\/\/www.bullscreen.in\/news\/wp-json\/wp\/v2\/posts\/3055\/revisions"}],"predecessor-version":[{"id":3058,"href":"https:\/\/www.bullscreen.in\/news\/wp-json\/wp\/v2\/posts\/3055\/revisions\/3058"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.bullscreen.in\/news\/wp-json\/wp\/v2\/media\/3056"}],"wp:attachment":[{"href":"https:\/\/www.bullscreen.in\/news\/wp-json\/wp\/v2\/media?parent=3055"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bullscreen.in\/news\/wp-json\/wp\/v2\/categories?post=3055"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bullscreen.in\/news\/wp-json\/wp\/v2\/tags?post=3055"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}